Evidence map›Paper›PMID 23910468›Full record

ReviewOtolaryngologic clinics of North America2013

Impact of human papillomavirus on oropharyngeal cancer biology and response to therapy: implications for treatment.

Juliana Bonilla-Velez, Edmund A Mroz, Rebecca J Hammon, James W Rocco

Abstract readReview
In one paragraph

Review in Otolaryngologic clinics of North America, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Guideline
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Survival analysis of 287 oropharyngeal squamous cell carcinoma patients in a single institution: a retrospective comparison of two consecutive time intervals with surgical and conservative treatment approaches.European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery · 2017
    Article
  13. Article
  14. Intra-tumor heterogeneity in head and neck cancer and its clinical implications.World journal of otorhinolaryngology - head and neck surgery · 2016
    Article
  15. Article
  16. Article
  17. Molecular Aspects of Head and Neck Cancer Therapy.Hematology/oncology clinics of North America · 2015
    Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Juliana Bonilla-VelezDepartment of Otolaryngology, Massachusetts Eye and Ear Infirmary, Harvard Medical School, 243 Charles Street, Boston, MA 02114, USA.
Edmund A Mroz
Rebecca J Hammon
James W Rocco

Funding

Bcl-2 as a Biomarker for Prognosis and Therapy of Head and Neck CancerR01DE022087 · NIDCR · OHIO STATE UNIVERSITY · PI ROCCO, JAMES W · 2011 to 2015
$2.9M
RESEARCH TRAINING IN OTOLARYNGOLOGYT32DC000020 · NIDCD · MASSACHUSETTS EYE AND EAR INFIRMARY · PI JUNG, DAVID H, SIMONYAN, KRISTINA · 1990 to 2025
$2.4M
Phase II Clinical Trial of AZD2171 Monotherapy In Recurrent Head and Neck CancerR21CA119591 · NCI · MASSACHUSETTS GENERAL HOSPITAL · PI ROCCO, JAMES W · 2006 to 2007
$588k
NCI NIH HHS R21 CA119591NIDCD NIH HHS T32 DC000020NIDCR NIH HHS R01 DE022087
6 · The paper itself

Abstract

Oropharyngeal squamous cell carcinoma (OPSCC) originating from human papillomavirus infection has emerged as a new entity in head and neck cancer, defining a subset of patients with distinct carcinogenesis, risk factor profiles, and clinical presentation that show markedly improved survival than patients with classic OPSCC. De-escalation of therapy and identification of relevant biomarkers to aid in patient selection are actively being investigated. This review addresses the implications of these findings in clinical care.

Indexed as

Antineoplastic AgentsCarcinoma, Squamous CellHumansOncogene Proteins, ViralOropharyngeal NeoplasmsPapillomaviridaePapillomavirus InfectionsPapillomavirus VaccinesAntineoplastic AgentsOncogene Proteins, ViralPapillomavirus VaccinesClinical implicationsHPV-positive oropharyngeal cancerTreatment implications

Identifiers

PMID23910468
PMCPMC3740406

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.